Clinical Trials Browser

ivarmacitinib × 90 days × Clear all

NCT06519526 2026-01-12

Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma

Phase 2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT07313202 2025-12-31

Ivarmacitinib in Advanced Solid Tumors: A Prospective, Two-Cohort, Two-Phase Exploratory Study in Patients Discontinued Due to Immune Intolerance

Phase 2 Not yet recruiting

Other solid neoplasm

Patients With Advanced Solid Tumors Who Discontinued Treatment Due to irAE